Company: APM
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001213900-25-111548
Chunk: 394

Company: Aptorum Group Ltd
Filing Date: 2025-11-17
Form: F-1
Chunk 394
---
 to the Acquisition are subject to material change upon the completion of a definitive merger agreement and re-determination of the accounting acquirer and purchase price allocation as of the date any closing, which may be substantially different from their estimated amounts used in the preparation of this unaudited pro forma financial information. Amounts allocated to patents are generally subject to amortization over the lives of the patents, as definite-live intangible assets. Amounts allocated to in-process research and development are subject periodic impairment, including upon the abandonment of programs. Amounts allocated to goodwill are subject to periodic impairment, including upon Company market price declines. Each Aptorum Class A Ordinary share is exchanged for one share of common stock of the combined company. Each Aptorum Class B Ordinary Share is exchanged for one share of common stock of the combined company and one share of preferred stock. DiamiR’s historical stockholder equity balances are eliminated.

| (e) | The adjustment represents the estimated transaction costs                                                                                   
 of the Acquisition, including legal and professional fees directly attributable to the Acquisition and settled in cash, as well as warrants 
 to be issued to Wainwright upon consummation of the Merger that have a fair value of approximately $500,000 and are currently presumed      
 to be classified within stockholders’ equity.                                                                                               |

246

| (f) | Reflects the automatic conversion in connection with the Domestication                                                                
 of 1,796,934 Aptorum Class B Ordinary Shares into 1,796,934 shares of common stock of Aptorum Delaware and 1,796,934 shares of Series 
 A preferred stock of Aptorum Delaware.                                                                                                |

| (g) | Pro forma shares of common stock outstanding include: |

| Aptorum Class A Ordinary Shares at June 30, 2025 that were converted into common stock |     |  5,346,823 |
| Conversion of Aptorum Class B Ordinary Shares into common stock                        |     |  1,796,934 |
| Conversion of note payable into common stock                                           |     |  1,338,223 |
| Exercise of warrants                                                                   |     |     54,054 |
| Conversion of Class A Ordinary Shares issued in Offering into common stock             |     |  1,000,000 |
| Issuance of common stock to DiamiR shareholders in merger                              |     | 19,917,413 |
| Pro Forma Common Stock Outstanding at June 30, 2025                                    |     | 29,453,447 |